HIGHLIGHTS
- who: Chiara Lestuzzi from the Hospital, China have published the paper: The puzzling clinical presentation of fluoropyrimidines cardiotoxicity, in the Journal: (JOURNAL)
- what: This approach has been demonstrated to be effective in detecting several asymptomatic or oligosymptomatic toxicities, probably missed by most of the retrospective studies published so far, which included only those patients with clinical symptoms referred to the caring oncologists . This is the main reason why the authors are presently giving to all the patients beginning a CT with capecitabine the advice to avoid any unusual physical effort when on therapy.
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.